If You're Listening cover image

Is the century-long search for a weight loss drug over?

If You're Listening

CHAPTER

Introduction

This chapter explores the sudden increase in value of Novo Nordisk, Europe's most valuable company, and the role of their drug semaglutide in treating type 2 diabetes and aiding weight loss, with endorsements from celebrities like Elon Musk and Amy Schumer.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner